Tear Volume and Tear Total Lipid Concentration Following Administration of Acoltremon 0.003%

Dry Eye

Jun 15, 2026

In this video, David L. Wirta, MD, presents: "Tear Volume and Tear Total Lipid Concentration Following Administration of Acoltremon 0.003%".

Related Publications

Tear Production Associated with a Novel TRPM8 Agonist (AR-15112): Results from Phase 3 Pivotal Clinical Studies (COMET-2 and COMET-3)

Dry Eye

Dr Walter Whitley, OD, MBA, FAAO, presents this clinical research summary video on tear production associated with a novel TRPM8 agonist (AR-15112), sharing results from Phase 3 pivotal clinical…

Learn More

Acoltremon 0.003% Leads to a Statistically Significant Increase in Tear Volume and Tear Total Lipid Concentration: Phase 3b Study Results

Dry Eye

Dr Nate Lightizer, OD, presents this clinical research summary video on how Acoltremon 0.003% leads to a statistically significant increase in tear volume and tear total lipid concentration, based on…

Learn More

Improvement in Visual Tasking Activities and Workplace Productivity After 14 Days of Acoltremon 0,0003% Treatment: Integrated Analysis of COMET Studies

Dry Eye

Dr Cory Lappin, OD, MS, FAAO, presents this clinical research summary video examining improvement in visual tasking activities and workplace productivity after 14 days of Acoltremon 0.0003% treatment…

Learn More

↑